KehDih Lai

Title: Innovations and Contributions of KehDih Lai

Introduction

KehDih Lai is a notable inventor based in Yardley, PA (US), recognized for his significant contributions to the field of biotechnology. With a total of 5 patents, he has made remarkable strides in developing methods and technologies that have the potential to impact medical science and therapeutic applications.

Latest Patents

One of KehDih Lai's latest patents is focused on a method of using a genetically modified mouse that expresses human albumin. This patent details non-human animal genomes, non-human animal cells, and non-human animals that comprise a humanized albumin locus. The methods provided allow for the assessment of in vivo efficacy of human-albumin-targeting reagents, such as nuclease agents designed to target human albumin. Another significant patent involves Factor XI A2 domain-binding antibodies. This disclosure provides antibodies that bind to the A2 domain of Factor XI (FXI) and methods of using these antibodies to inhibit blood clot formation without affecting hemostasis. These innovations have the potential to treat blood clotting diseases and disorders, making them crucial in the medical field.

Career Highlights

KehDih Lai has worked with prominent companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and the development of his innovative patents.

Collaborations

Throughout his career, KehDih Lai has collaborated with talented individuals such as Dan Chalothorn and Lori C. Morton. These collaborations have likely fostered an environment of innovation and creativity, leading to the development of groundbreaking technologies.

Conclusion

KehDih Lai's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical science and therapeutic solutions.